Skip to main content
Clinical Trials/NCT02002559
NCT02002559
Completed
Not Applicable

Endoscopic Surveillance Comparing Narrow Band Imaging (NBI) Against Lugol Chromoendoscopy for Detection of Synchronous Superficial Squamous Esophageal Neoplasia Among High Risk Patients

Chinese University of Hong Kong0 sites180 target enrollmentApril 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Superficial Esophageal Neoplasia
Sponsor
Chinese University of Hong Kong
Enrollment
180
Primary Endpoint
Diagnostic accuracy of superficial esophageal neoplasia
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study aimed to compare Narrow Band Imaging (NBI) against Lugol chromoendoscopy for diagnosis of early esophageal cancers among high risk patients.

Detailed Description

The investigators recruited consecutive patients with head and neck cancers, history of squamous esophageal cancers treated by chemoradiotherapy or endoscopic resection. Endoscopic surveillance first started with NBI for detection and characterization of early esophageal cancers through observation of abnormal intrapapillary capillary loops (IPCL). Superficial esophageal neoplasia were diagnosed by IPCL Type IV, V1,V2 and Vn. Lugol chromoendoscopy would be performed subsequently and suspicious neoplasia were classified as understain or unstain lesions. The diagnostic accuracy, sensitivity and specificity of NBI were compared to Lugol chromoendoscopy with histology serving as a gold standard.

Registry
clinicaltrials.gov
Start Date
April 2006
End Date
December 2010
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Philip Wai Yan Chiu

Professor

Chinese University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Patients with Head and Neck Cancer
  • Patients with esophageal cancer treated by chemoradiotherapy and in remission for 2 years
  • Patients with esophageal cancer treated by endoscopic resection
  • Age 18 to 80

Exclusion Criteria

  • Allergy to Lugol iodine
  • Previous esophagectomy

Outcomes

Primary Outcomes

Diagnostic accuracy of superficial esophageal neoplasia

Time Frame: 1 month

Similar Trials